$NHI
NATIONAL HEALTH INVESTORS INC

2013 Q1 Form 10-Q Financial Statement

#000087786013000046 Filed on May 06, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $27.10M $23.14M
YoY Change 17.16% 5.46%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.510M $3.000M
YoY Change 17.0% -30.56%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.400M $3.400M
YoY Change 29.41% 17.24%
% of Gross Profit
Operating Expenses $13.09M $6.841M
YoY Change 91.27% 6.11%
Operating Profit $15.01M $17.22M
YoY Change -12.83% 11.15%
Interest Expense $1.123M $575.0K
YoY Change 95.3% 20.55%
% of Operating Profit 7.48% 3.34%
Other Income/Expense, Net $372.0K
YoY Change 175.56%
Pretax Income $14.99M $17.22M
YoY Change -12.96% 11.15%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $15.74M $18.35M
YoY Change -14.2% -3.9%
Net Earnings / Revenue 58.08% 79.31%
Basic Earnings Per Share $0.56 $0.66
Diluted Earnings Per Share $0.56 $0.66
COMMON SHARES
Basic Shares Outstanding 27.88M shares 27.78M shares
Diluted Shares Outstanding 27.91M shares 27.80M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.90M $18.70M
YoY Change 11.74% -11.38%
Cash & Equivalents $6.050M $6.927M
Short-Term Investments $14.85M $11.77M
Other Short-Term Assets $1.900M
YoY Change
Inventory
Prepaid Expenses
Receivables $2.240M $1.400M
Other Receivables $13.70M $9.700M
Total Short-Term Assets $23.90M $18.00M
YoY Change 32.78% -36.17%
LONG-TERM ASSETS
Property, Plant & Equipment $533.3M $396.3M
YoY Change 34.57% 21.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $8.375M $51.30M
YoY Change -83.67% -17.52%
Other Assets $1.600M $29.40M
YoY Change -94.56% 0.0%
Total Long-Term Assets $676.2M $554.9M
YoY Change 21.87% 12.35%
TOTAL ASSETS
Total Short-Term Assets $23.90M $18.00M
Total Long-Term Assets $676.2M $554.9M
Total Assets $700.1M $572.9M
YoY Change 22.21% 9.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.600M $2.800M
YoY Change 28.57% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.00M $20.90M
YoY Change 10.05% 5.56%
LONG-TERM LIABILITIES
Long-Term Debt $203.3M $95.30M
YoY Change 113.33% 92.91%
Other Long-Term Liabilities $5.600M $11.10M
YoY Change -49.55% 105.56%
Total Long-Term Liabilities $208.9M $106.4M
YoY Change 96.33% 94.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.00M $20.90M
Total Long-Term Liabilities $208.9M $106.4M
Total Liabilities $231.8M $127.3M
YoY Change 82.08% 70.63%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $469.8M $467.4M
YoY Change 0.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $457.5M $445.6M
YoY Change
Total Liabilities & Shareholders Equity $700.1M $572.9M
YoY Change 22.21% 9.73%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income $15.74M $18.35M
YoY Change -14.2% -3.9%
Depreciation, Depletion And Amortization $4.400M $3.400M
YoY Change 29.41% 17.24%
Cash From Operating Activities $23.85M $21.25M
YoY Change 12.23% 22.43%
INVESTING ACTIVITIES
Capital Expenditures -$1.500M -$4.900M
YoY Change -69.39% 1533.33%
Acquisitions
YoY Change
Other Investing Activities -$700.0K $800.0K
YoY Change -187.5% -87.3%
Cash From Investing Activities -$2.145M -$4.062M
YoY Change -47.19% -167.48%
FINANCING ACTIVITIES
Cash Dividend Paid $24.79M $24.14M
YoY Change 2.69% 44.13%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$24.82M -$26.14M
YoY Change -5.05% 429.02%
NET CHANGE
Cash From Operating Activities $23.85M $21.25M
Cash From Investing Activities -$2.145M -$4.062M
Cash From Financing Activities -$24.82M -$26.14M
Net Change In Cash -$3.122M -$8.959M
YoY Change -65.15% -148.6%
FREE CASH FLOW
Cash From Operating Activities $23.85M $21.25M
Capital Expenditures -$1.500M -$4.900M
Free Cash Flow $25.35M $26.15M
YoY Change -3.06% 48.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 nhi Equity Method Investment Summarized Financial Information Operating Expenses
EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses
4056000 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
4301000 USD
CY2013Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3590000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1815000 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2240000 USD
CY2013Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
22127000 USD
CY2012Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
18495000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9786000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7555000 USD
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
469569000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
467843000 USD
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1580000 USD
CY2012Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1432000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2012Q1 us-gaap Allowance For Loan And Lease Losses Recoveries Of Bad Debts
AllowanceForLoanAndLeaseLossesRecoveriesOfBadDebts
0 USD
CY2013Q1 us-gaap Allowance For Loan And Lease Losses Recoveries Of Bad Debts
AllowanceForLoanAndLeaseLossesRecoveriesOfBadDebts
4037000 USD
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11681 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11964 shares
CY2012Q4 us-gaap Assets
Assets
705981000 USD
CY2013Q1 us-gaap Assets
Assets
700141000 USD
CY2012Q4 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
1611000 USD
CY2013Q1 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
1611000 USD
CY2013Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
4088000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
4088000 USD
CY2013Q1 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
14845000 USD
CY2012Q4 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
12884000 USD
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
8796000 USD
CY2013Q1 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
10757000 USD
CY2013Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
0 USD
CY2012Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
0 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9172000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6050000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15886000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6927000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3122000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8959000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.695
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.65
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27876176 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27857217 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27876176 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27857217 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
279000 USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
279000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17974000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18758000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
180000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
18758000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
18154000 USD
CY2013Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4922000 USD
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2673000 USD
CY2012Q4 us-gaap Cost Method Investments
CostMethodInvestments
38132000 USD
CY2013Q1 us-gaap Cost Method Investments
CostMethodInvestments
38132000 USD
CY2013Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
203250000 USD
CY2012Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
203250000 USD
CY2013Q1 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
12507000 USD
CY2012Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
12172000 USD
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
1334000 USD
CY2013Q1 us-gaap Deferred Revenue
DeferredRevenue
1294000 USD
CY2013Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
4415000 USD
CY2012Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
3365000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
915000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
1234000 USD
CY2013Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19375000 USD
CY2013Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
19375000 USD
CY2012Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
24793000 USD
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2012Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
12370000 USD
CY2013Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
13652000 USD
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1176000 USD
CY2012Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
0 USD
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
25000 USD
CY2012Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
0 USD
CY2013Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
6189000 USD
CY2013Q1 us-gaap Equity Method Investments
EquityMethodInvestments
8375000 USD
CY2012Q4 us-gaap Equity Method Investments
EquityMethodInvestments
8353000 USD
CY2013Q1 nhi Depreciation Discontinued Operations
DepreciationDiscontinuedOperations
0 USD
CY2012Q1 nhi Equity Method Investment Summarized Financial Information Lease Expense
EquityMethodInvestmentSummarizedFinancialInformationLeaseExpense
0 USD
CY2013Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 USD
CY2012Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 USD
CY2013Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
0 USD
CY2013Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
28972000 USD
CY2013Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
1250000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3089000 USD
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2786000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
14828000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
17217000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17217000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14986000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.62
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.53
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.53
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.62
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1133000 USD
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
915000 USD
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.04
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.03
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.04
CY2013Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
22000 USD
CY2012Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-665000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-440000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-40000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-40000 USD
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
133000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
324000 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
1123000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
575000 USD
CY2012Q1 us-gaap Interest Income Operating
InterestIncomeOperating
1702000 USD
CY2013Q1 us-gaap Interest Income Operating
InterestIncomeOperating
1969000 USD
CY2012Q1 us-gaap Interest Paid
InterestPaid
534000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
1070000 USD
CY2013Q1 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
971000 USD
CY2013Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
637043000 USD
CY2012Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
636994000 USD
CY2013Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1052000 USD
CY2012Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1060000 USD
CY2013Q1 us-gaap Land
Land
58869000 USD
CY2012Q4 us-gaap Land
Land
58869000 USD
CY2012Q1 us-gaap Legal Fees
LegalFees
91000 USD
CY2013Q1 us-gaap Legal Fees
LegalFees
277000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
231765000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
237934000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
700141000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
705981000 USD
CY2012Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
64000000 USD
CY2013Q1 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
64000000 USD
CY2013Q1 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
0 USD
CY2012Q1 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
2000000 USD
CY2012Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
84250000 USD
CY2013Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
80059000 USD
CY2013Q1 us-gaap Marketable Securities
MarketableSecurities
14845000 USD
CY2012Q4 us-gaap Marketable Securities
MarketableSecurities
12884000 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
10865000 USD
CY2013Q1 us-gaap Minority Interest
MinorityInterest
10869000 USD
CY2013Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
-176000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26144000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24823000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4062000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2145000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21247000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23846000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
15743000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
18350000 USD
CY2013Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
180000 USD
CY2012Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2013Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
1463000 USD
CY2013Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
176000 USD
CY2013Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
107 properties
CY2013Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
23
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
13085000 USD
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
6841000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
15008000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17217000 USD
CY2012Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
21296000 USD
CY2013Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
25050000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
408000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2231000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
270000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
408000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1961000 USD
CY2012Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
0 USD
CY2013Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
836000 USD
CY2013Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
24793000 USD
CY2012Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
24144000 USD
CY2012Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
52000 USD
CY2013Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
0 USD
CY2012Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
4881000 USD
CY2012Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2012Q1 us-gaap Percentage Rent
PercentageRent
1478000 USD
CY2013Q1 us-gaap Percentage Rent
PercentageRent
1437000 USD
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1892000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2004000 USD
CY2012Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
871000 USD
CY2013Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
154000 USD
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
146000 USD
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2012Q1 us-gaap Profit Loss
ProfitLoss
18350000 USD
CY2013Q1 us-gaap Profit Loss
ProfitLoss
15923000 USD
CY2012Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
163146000 USD
CY2013Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
167549000 USD
CY2012Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
698536000 USD
CY2013Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
700834000 USD
CY2012Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
535390000 USD
CY2013Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
533285000 USD
CY2012Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
1000 USD
CY2012Q1 us-gaap Revenues
Revenues
24058000 USD
CY2013Q1 us-gaap Revenues
Revenues
28071000 USD
CY2013Q1 us-gaap Secured Debt
SecuredDebt
19250000 USD
CY2012Q4 us-gaap Secured Debt
SecuredDebt
19250000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1250 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1250 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
504994 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
323330 shares
CY2012Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
688337 shares
CY2011Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
509422 shares
CY2013Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
516674 shares
CY2012Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
211675 shares
CY2013Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
146000 USD
CY2012Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1431000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
457507000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
457182000 USD
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
468376000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
468047000 USD
CY2013Q1 us-gaap Straight Line Rent
StraightLineRent
1283000 USD
CY2012Q1 us-gaap Straight Line Rent
StraightLineRent
1062000 USD
CY2013Q1 us-gaap Unrealized Gain Loss On Interest Rate Cash Flow Hedges Pretax Accumulated Other Comprehensive Income Loss
UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
270000 USD
CY2012Q1 us-gaap Unrealized Gain Loss On Interest Rate Cash Flow Hedges Pretax Accumulated Other Comprehensive Income Loss
UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
0 USD
CY2012Q4 us-gaap Unsecured Debt
UnsecuredDebt
120000000 USD
CY2013Q1 us-gaap Unsecured Debt
UnsecuredDebt
120000000 USD
CY2013Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates -</font><font style="font-family:inherit;font-size:10pt;"> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
27876176 shares
CY2012Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
27776104 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27911584 shares
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27803222 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27876176 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27776104 shares
CY2012Q1 nhi Amount Of Dilutive Securities Stock Options
AmountOfDilutiveSecuritiesStockOptions
27118 shares
CY2013Q1 nhi Amount Of Dilutive Securities Stock Options
AmountOfDilutiveSecuritiesStockOptions
35408 shares
CY2013Q1 nhi Equity Method Investment Summarized Financial Information Lease Expense
EquityMethodInvestmentSummarizedFinancialInformationLeaseExpense
2081000 USD
CY2012Q1 nhi Equity Method Investment Summarized Financial Information Operating Expenses
EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses
0 USD
CY2013Q1 nhi Depreciation Continuing Operations
DepreciationContinuingOperations
4415000 USD
CY2012Q1 nhi Depreciation Continuing Operations
DepreciationContinuingOperations
3264000 USD
CY2012Q1 nhi Depreciation Discontinued Operations
DepreciationDiscontinuedOperations
101000 USD
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27876176 shares
CY2013Q1 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
144000 USD
CY2012Q1 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
125000 USD
CY1998Q3 nhi Investment In Cumulative Preferred Stock
InvestmentInCumulativePreferredStock
2000000 shares
CY2013Q1 nhi Mortgage Loans On Real Estate Impairment
MortgageLoansOnRealEstateImpairment
4037000 USD
CY2013Q1 nhi Number Of Basis Points Over Libor
NumberOfBasisPointsOverLibor
21
CY2013Q1 nhi Number Of Health Care Properties Related To Mortgage Notes Receivables
NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables
27 properties
CY2013Q1 nhi Number Of Lessees
NumberOfLessees
18
CY2013Q1 nhi Original Cost Of Cost Method Investments
OriginalCostOfCostMethodInvestments
38132000 USD
CY2013Q1 nhi Real Estate Investment Property Nonportfolio Assets
RealEstateInvestmentPropertyNonportfolioAssets
710000 USD
CY2013Q1 nhi Real Estate Investment Property Portfolio Assets
RealEstateInvestmentPropertyPortfolioAssets
699998000 USD
CY2012Q4 nhi Real Estate Purchase Liabilities
RealEstatePurchaseLiabilities
4256000 USD
CY2013Q1 nhi Real Estate Purchase Liabilities
RealEstatePurchaseLiabilities
4256000 USD
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000877860
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
NATIONAL HEALTH INVESTORS INC

Files In Submission

Name View Source Status
0000877860-13-000046-index-headers.html Edgar Link pending
0000877860-13-000046-index.html Edgar Link pending
0000877860-13-000046.txt Edgar Link pending
0000877860-13-000046-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
nhi-20130331.xml Edgar Link completed
nhi-20130331.xsd Edgar Link pending
nhi-20130331_cal.xml Edgar Link unprocessable
nhi-20130331_def.xml Edgar Link unprocessable
nhi-20130331_lab.xml Edgar Link unprocessable
nhi-20130331_pre.xml Edgar Link unprocessable
nhi-3312013x10q.htm Edgar Link pending
nhi-3312013x10qex311.htm Edgar Link pending
nhi-3312013x10qex312.htm Edgar Link pending
nhi-3312013x10qex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending